Abstract
We report the case of a patient in whom bacterial endocarditis developed on a native valve after variceal sclerotherapy. We are concerned about the discrepant recommendations for antibiotic prophylaxis in the literature and consider that our report, which we take to be the first, suggests reasons for prophylactic antibiotic treatment in selected patients undergoing sclerotherapy.